Abstract:Objective To study values of polysomnography monitoring (PSG) combined with pulmonary function and arterial blood gas analysis for long-term oxygen therapy (LTOT) in chronic hypoxic disease. Methods A total of 120 subjects as chronic obstructive pulmonary disease (COPD) of stable period from June 2016 to June 2017 were enrolled and divided randomly into control and observation groups, each of 60 cases; patients in control group received common drug treatment and patients in observation group adopted common treatment combined with LTOT, at least 15?h oxygen inhalation per day, 2?L/min; then to compare differences of hour ratio of nocturnal oxygen saturation < 90% time to total sleep time (SIT90) and apnea hypopnea index (AHI), FEV1% and FEV1% predicted value, PaCO2 and PaO2 were measured by PSG before treatment, one, three and six months after treatment. Results The SIT90, AHI, FEV1/FVC, FEV1 real/pre, PaCO2 and PaO2 of the control group were compared with those of the observation group before treatment, 1 month, 3 months and 6 months after treatment. The results of variance analysis of repeated measurement data were as follows:① SIT90, AHI, FEV1%, FEV1% pre, PaCO2 and PaCO2 at different time points were all different (P?0.05); ② SIT90, AHI, FEV1%, FEV1% pre and PaCO2 between the control group and the observation group were different (P?0.05); compared with the control group, SIT90, AHI and PaCO2 in the observation group were lower, and FEV1%, FEV1% pre, and PaO2 were higher.③ There were differences in the trend of SIT90, AHI, FEV1%, FEV1% pre, PaCO2 and PaO2 between the control group and the observation group (P?0.05). Conclusions LTOT can improve nocturnal anoxia, pulmonary function and arterial blood gas for patients with COPD stable period.